Skip to search formSkip to main contentSkip to account menu

Rozerem

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

ramelteon
ramelteon 8 MG Oral Tablet [Rozerem]ramelteon Oral Tablet [Rozerem]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Drug Discovery Process: A Case Study on Takeda
IntroductionPharmaceutical research and development of drugs is well-known for its high uncertainty (Kuwashima, 2006; Pisano… 
Review
2010
Review
2010
[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).].
Review
2009
Review
2009
[A novel therapeutic drug: ramelteon].
Current treatment of insomnia with hypnotics, GABA(A) receptor modulators, induces various side effects, including cognitive… 
2008
2008
Ramelteon (Rozerem??): A new class of sleep aid
2007
2007
Ramelteon (Rozerem): A Novel Treatment Option for Patients with Insomnia
(BZD) receptors as allosteric modulators, they are classified as controlled substances and carry some risk for dependence or… 
2006
2006
Ramelteon (Rozerem) for insomnia.
Ramelteon is safe and effective for decreasing the time to persistent sleep in patients with chronic insomnia. It does not have… 
Review
2006
Review
2006
Ramelteon (rozerem) a novel approach for insomnia treatment.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)